Insulin sentizier for PCOS women undergoing ICSI

Pioglitazone hydrochloride in PCOS women undergoing ICSI with antagonist protocol: A Multicenter Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201308000579176

Enrollment

220

Registered

2013-07-04

Start date

2013-09-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Fertility-female PCOS infertile women

Interventions

Insulin Sensitizer

Control

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with PCSO as defined by Androgen excess-PCOS Society Task Force (2009)

Exclusion criteria

Exclusion criteria: Diabetes Hypertension Intrauterine pathology Cholclate cyst Morbid obesity (BMI >35)

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy with cardiac pulsation	—

Secondary

Measure	Time frame
Blastocyst formation ;Ovarian hyperstimulation;Spontaneous miscarriage	—

Countries

Egypt, Libyan Arab Jamahiriya

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026